COVID-19 ImmunoRank™ Neutralization MICRO-ELISA
8 Sept 2020The COVID-19 ImmunoRank™ Neutralization MICRO-ELISA is a test for semi-quantitative detection of SARS-CoV-2 neutralizing antibodies in plasma or serum. This assay is intended for detection of circulating SARS-CoV-2 neutralizing antibodies of all Ig classes and to identify individuals who have mounted an adaptive immune response to SARS-CoV-2 indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of neutralizing antibodies confers protective immunity. The COVID-19 ImmunoRank™ Neutralization MICRO-ELISA test should not be used to diagnose acute SARS-CoV-2 infection. Use of this test is limited to research use only applications and not for In vitro diagnostic use.
Related Products
Request Quote for All Products
COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Kit
Leinco TechnologiesThe COVID-19 ImmunoRank™ Neutralization MICRO-ELISA test for detection of circulating SARS-CoV-2 neutralizing antibodies. The assay is designed to detect antibodies of all Ig classes in human plasma or serum that bind to the SARS-CoV-2 receptor binding domain (RBD) and are capable of blocking the binding of the RBD to angiotensin-converting enzyme 2 (ACE2), the viral entry receptor on the surface of target cells.